**See all studies/citations on GHK 7% page here
Studies suggest subcutaneous administration achieves 7085% bioavailability compared to oral routes, though oral protocols at 100150mg compensate for first-pass metabolism
GHK-Cu as an anti-inflammatory agent Numerous studies have shown that GHK-Cu may reduce inflammation and free radical damage, repair protective skin barrier proteins, and improve the rate of healing following tissue injury [1]
Each targets a distinct mechanism of skin aging, collagen synthesis, wound healing, or telomere maintenance, giving geroscience researchers a well-characterized toolkit for studying biological aging processes at the molecular level
This product comes as lyophilized powder and is not reconstituted
That idea led us to develop and study LA3IK, a short peptide derived from MIEN1 that can interfere with EGFRERBB2 interaction. The research team found that the peptide LA3IK interferes with this pairing